Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

Don’t ignore sleep apnea as a ‘lifestyle condition’—among a host of other medical issues, it has been shown to cause and ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

USA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing ...

A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will suffer ...

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial.

Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million ...

Some 61 million people live with diabetes in Europe, of whom about 90% have type 2 diabetes (T2D) [1], in which the body may ...

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

As global populations age, the prevalence of type 2 diabetes and its associated complications, such as sarcopenia, continues to rise.

The findings, based on more than 3 million pregnancies and published by The BMJ, showed that metformin can continue to be ...